DE69728139T2 - Pyrrolopyrrolone als inhibitoren von neutrophiler elastase - Google Patents

Pyrrolopyrrolone als inhibitoren von neutrophiler elastase Download PDF

Info

Publication number
DE69728139T2
DE69728139T2 DE69728139T DE69728139T DE69728139T2 DE 69728139 T2 DE69728139 T2 DE 69728139T2 DE 69728139 T DE69728139 T DE 69728139T DE 69728139 T DE69728139 T DE 69728139T DE 69728139 T2 DE69728139 T2 DE 69728139T2
Authority
DE
Germany
Prior art keywords
neutrophiler
pyrrolopyrrolone
elastase
inhibitors
neutrophiler elastase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728139T
Other languages
German (de)
English (en)
Other versions
DE69728139D1 (de
Inventor
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Simon John Fawcett Macdonald
Pritom Shah
Robin Andrew Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69728139D1 publication Critical patent/DE69728139D1/de
Publication of DE69728139T2 publication Critical patent/DE69728139T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
DE69728139T 1996-03-28 1997-03-26 Pyrrolopyrrolone als inhibitoren von neutrophiler elastase Expired - Fee Related DE69728139T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (2)

Publication Number Publication Date
DE69728139D1 DE69728139D1 (de) 2004-04-22
DE69728139T2 true DE69728139T2 (de) 2004-10-21

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728139T Expired - Fee Related DE69728139T2 (de) 1996-03-28 1997-03-26 Pyrrolopyrrolone als inhibitoren von neutrophiler elastase

Country Status (30)

Country Link
US (3) US5994344A (Direct)
EP (1) EP0891362B1 (Direct)
JP (1) JP4118337B2 (Direct)
KR (1) KR20000005039A (Direct)
CN (1) CN1067075C (Direct)
AP (1) AP823A (Direct)
AR (1) AR006401A1 (Direct)
AT (1) ATE261969T1 (Direct)
AU (1) AU726649B2 (Direct)
BR (1) BR9708449A (Direct)
CA (1) CA2250209A1 (Direct)
CO (1) CO4790152A1 (Direct)
CZ (1) CZ309798A3 (Direct)
DE (1) DE69728139T2 (Direct)
DK (1) DK0891362T3 (Direct)
EA (1) EA001437B1 (Direct)
EE (1) EE9800335A (Direct)
ES (1) ES2217404T3 (Direct)
HU (1) HUP9900567A3 (Direct)
IL (1) IL125859A0 (Direct)
IS (1) IS4837A (Direct)
NO (1) NO984470L (Direct)
NZ (1) NZ331490A (Direct)
PE (1) PE55298A1 (Direct)
PL (1) PL329153A1 (Direct)
PT (1) PT891362E (Direct)
SK (1) SK132498A3 (Direct)
TR (1) TR199801935T2 (Direct)
WO (1) WO1997036903A1 (Direct)
YU (1) YU41198A (Direct)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719187D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
MXPA05009771A (es) 2003-03-14 2005-10-26 Ono Pharmaceutical Co Derivados heterociclicos que contienen nitrogeno y medicamentos que los contienen como el ingrediente activo.
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
SG146673A1 (en) 2004-09-13 2008-10-30 Ono Pharmaceutical Co Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
WO2007105637A1 (ja) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
CN104758281A (zh) * 2007-04-23 2015-07-08 西佳技术公司 用于治疗和预防正痘病毒感染和相关疾病的化合物、组合物和方法
MX2010005298A (es) 2007-11-16 2010-06-30 Rigel Pharmaceuticals Inc Compuestos de carboxamida, sulfonamida y amina para trastornos metabolicos.
EP2231666B1 (en) 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
CN112079769A (zh) 2008-04-23 2020-12-15 里格尔药品股份有限公司 用于治疗代谢障碍的甲酰胺化合物
AU2013363783B2 (en) * 2012-12-18 2018-02-08 Chiesi Farmaceutici S.P.A. Novel compounds
JP7672641B2 (ja) 2019-09-17 2025-05-08 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
MX2022012942A (es) 2020-04-16 2023-01-11 Mereo Biopharma 4 Ltd Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina.
IL312002A (en) 2021-10-20 2024-06-01 Mereo Biopharma 4 Ltd Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
YU41198A (sh) 1999-09-27
CZ309798A3 (cs) 1999-02-17
KR20000005039A (ko) 2000-01-25
SK132498A3 (en) 1999-08-06
AU726649B2 (en) 2000-11-16
ES2217404T3 (es) 2004-11-01
EP0891362B1 (en) 2004-03-17
US5994344A (en) 1999-11-30
AU2291797A (en) 1997-10-22
IL125859A0 (en) 1999-04-11
US6057457A (en) 2000-05-02
AP823A (en) 2000-04-25
NO984470D0 (no) 1998-09-25
NZ331490A (en) 2000-06-23
US6215002B1 (en) 2001-04-10
HUP9900567A2 (hu) 1999-06-28
AR006401A1 (es) 1999-08-25
BR9708449A (pt) 1999-08-03
JP2000507950A (ja) 2000-06-27
CO4790152A1 (es) 1999-05-31
EP0891362A1 (en) 1999-01-20
ATE261969T1 (de) 2004-04-15
AP9801351A0 (en) 1998-09-30
PE55298A1 (es) 1998-09-19
EA001437B1 (ru) 2001-02-26
HUP9900567A3 (en) 2001-02-28
PT891362E (pt) 2004-08-31
CA2250209A1 (en) 1997-10-09
JP4118337B2 (ja) 2008-07-16
NO984470L (no) 1998-11-25
PL329153A1 (en) 1999-03-15
TR199801935T2 (xx) 1999-03-22
DK0891362T3 (da) 2004-07-12
CN1067075C (zh) 2001-06-13
CN1219935A (zh) 1999-06-16
WO1997036903A1 (en) 1997-10-09
IS4837A (is) 1998-08-28
EE9800335A (et) 1999-04-15
DE69728139D1 (de) 2004-04-22
EA199800773A1 (ru) 1999-06-24

Similar Documents

Publication Publication Date Title
DE69728139T2 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
ATE244216T1 (de) Ketobenzamide als calpain-inhibitoren
DE59710982D1 (de) Cycloalkano-pyridine als CETP-Inhibitoren
FI944804L (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69735316D1 (de) Erkennung von Extravasation
ID18406A (id) Palang penggantung pakaian
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
FI973282A7 (fi) Trombiinin inhibiittoreita
DE69824199D1 (de) Lactamverbindungen als metalloprotease-inhibitoren
DK0858464T3 (da) Thrombin-inhibitorer
PT927183E (pt) Inibidores espirociclicos de metaloproteases
DE59711714D1 (de) Thrombininhibitoren
DE69736109D1 (de) Differenzierungsinhibitor
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE69733263D1 (de) Markierte elastase-inhibitoren
FI964781L (fi) Uusia elastaasi-inhibiittoreita
ID16838A (id) Komposisi dekafluoropentana
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
DE69709159D1 (de) Kreuz-dimierisierung von olefinen
DE69700722D1 (de) Redistribution von Polycarbonat
DE69717631D1 (de) Bestimmung von teilchenförmigen verunreinigungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee